Company news
Itonis, Inc. (OTC:ITNS) news
Itonis, Inc. news releases on 6ix. Latest, Jan 5, 2026: Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl
Press releases & updates
Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl
January 5, 2026
Itonis, Inc. announces “Emesyl® Plus” homeopathic nasal spray containing Premium Hemp Oil
September 26, 2018
Itonis, Inc. Provides Update for its Emesyl® Anti-nausea Product Sales
January 2, 2018
Itonis, Inc. Announces Its Emesyl Anti-Nausea Product is Again Available for Purchase via Amazon.com
September 27, 2016
Itonis, Inc. Signs Facebook Ad Campaign for Its Emesyl Anti-Nausea Homeopathic Product in California Market
September 20, 2016
Itonis, Inc. to Air Emesyl Commercial Spots in the Washington, DC Market for Its Emesyl Anti-Nausea Homeopathic Product
September 2, 2016
Itonis, Inc. Announces 10,000 Commercial Spots for Its Emesyl Anti-Nausea Relief Have Begun
July 21, 2016
Itonis, Inc. Announces the Results of a Case Study Testing the Effects of Its Emesyl Nasal Relief on Severe Nausea
July 12, 2016
Itonis Pharmaceutical's EMESYL(TM) Nausea Relief Convenience Store Test Market Begins in Lodi, California
February 11, 2015
Itonis Distribution of Its EMESYL(TM) Nausea Relief Seeking Marketing Evaluation to Air Infomercial With "As Seen On TV"
February 10, 2015
Itonis Announces Hensley Brothers Distribution to Feature Emesyl™ Nausea Relief at the NACDS Total Store Expo
February 5, 2015
Itonis Pharmaceuticals Announces First Emesyl(R) Manufacturer Production Release Date
August 12, 2014
Itonis Pharmaceuticals Authorizes Start of Emesyl(R) Inaugural Production Run
June 25, 2014
Itonis Pharmaceuticals Completes Final Package Design, Enabling Start of Emesyl(R) Production
June 19, 2014
Itonis Pharmaceuticals Receives NDC Number From FDA to Enable Production and Marketing of Emesyl(R) Product
June 2, 2014
Itonis, Inc. Signs First Retail Merchant for MyECheck's Point of Sale Mobile Payment Application
May 8, 2014
Itonis, Inc. Readies Preliminary Packaging Design for Project "Cloud9" Cannabinoid-Based Product
April 24, 2014
Itonis Pharmaceuticals in Final Steps of NDC Registration With FDA for Emesyl Product
April 22, 2014
Itonis, Inc. Signed Exploratory Analysis Trial for Cloud9 Project With Valley Organics Inc.
April 16, 2014
Itonis, Inc. to Profit From Transactional Revenues by Marketing Its Licensed MyECheck Mobile App to Marijuana Dispensary Market
April 8, 2014
Itonis, Inc. Developing Cannabinoid-Based "Cloud9" Product
April 3, 2014
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
April 1, 2014
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
March 28, 2014
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
March 26, 2014
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
March 19, 2014
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
March 17, 2014
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
February 28, 2014
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
December 9, 2013
Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
December 4, 2013
Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy
December 2, 2013
Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy
November 25, 2013
Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
November 18, 2013
Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy
October 24, 2013
Itonis Pharmaceuticals and Dr. Charles Hensley Placed First Purchase Order to Produce Emesyl Nausea Remedy
September 23, 2013